Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gliceida Galarza Fortuna"'
Autor:
Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, Jinming Song, Carlos M. Morán-Segura, Jonathan V. Nguyen, Lazaros Lekakis, Sebastian Fernandez-Pol, Annie N. Samraj, Kikkeri N. Naresh, Mariola Vazquez-Martinez, Rachid C. Baz, Jay Y. Spiegel, Lekha Mikkilineni, John M. Gubatan, Surbhi Sidana, Andre de Menezes Silva Corraes, Nilesh M. Kalariya, Krina K. Patel, Kevin G. Shim, Rafael Fonseca, Christopher Ferreri, Peter M. Voorhees, Shambavi Richard, Cesar Rodriguez Valdes, Sireesha Asoori, Jeffrey L. Wolf, Andrew J. Cowan, Douglas W. Sborov, Frederick L. Locke, Yi Lin, Yinghong Wang, Doris K. Hansen
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract We report 14 cases of immune effector cell (IEC)-associated enterocolitis following chimeric antigen receptor T-cell (CAR-T) therapy in multiple myeloma, with a 1.2% incidence overall (0.2% for idecabtagene vicleucel and 2.2% for ciltacabtag
Externí odkaz:
https://doaj.org/article/785e1008853f44f183853c5a67a48d03
Autor:
Gliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, Kamal Kant Sahu, Shruti Adidam Kumar, Nishita Tripathi, Nicolas Sayegh, Neeraj Agarwal, Umang Swami, Benjamin L. Maughan, Haoran Li
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 3 (2024)
Thromboembolic events (TE) are a common complication in patients with metastatic renal cell carcinoma (mRCC) and are associated with poorer clinical outcomes. However, the incidence of TE and clinical and genomic characteristics of patients with mRCC
Externí odkaz:
https://doaj.org/article/3d723b5354184447bddff64aa213d2b4
Autor:
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira Mian, Luciano J. Costa, Douglas Sborov, Ghulam Rehman Mohyuddin
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Extra copies of chromosome 1q21 (+1q: gain = 3 copies, amp >= 4 copies) are associated with worse outcomes in multiple myeloma (MM). This systematic review assesses the current reporting trends of +1q, the efficacy of existing regimens on +1
Externí odkaz:
https://doaj.org/article/b50ed44cce2d4796a922eef0565c1e2e
Autor:
Anthony J. Febres-Aldana, Christopher A. Febres-Aldana, Kathrin Dvir, Gliceida Galarza-Fortuna, Michael Schwartz, Ana M. Medina, Vathany Sriganeshan
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Epstein–Barr virus infection is most commonly asymptomatic in the acute setting, where the end result of infection is the adoption of a viral latency phenotype. The virus can reactivate later in life leading to the abnormal proliferation of the inf
Externí odkaz:
https://doaj.org/article/8dbdc94acd354660ad379b2544d7a626
Publikováno v:
Chest. 156:A773